Learning & research

A comprehensive library of abstracts, scientific talks, scientific papers, and research on pulmonary vascular disease

Reset filters
Publication Types
28 May 2026

In this PH Community Call, we discussed: 

  • Sotatercept in Pulmonary Arterial Hypertension: Central, Hematologic, and Peripheral Mechanisms of Benefit
    Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension
Community Calls
24 April 2026

In this PH Community Call, we discussed: 

  • C–C Motif chemokine receptor-2 blockade ameliorates PH in rats and synergizes with a pulmonary vasodilator
  • Deep-learning networks accurately detect pulmonary hypertension in patients with idiopathic pulmonary fibrosis
  • Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertension
Community Calls
20 March 2026

In this PH Community Call, we discussed: 

  • Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension
  • Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia
  • Acute Hemodynamic Effects of Sotatercept
Community Calls
20 February 2026

In this PH Community Call, we discussed: 

  • Subcutaneous Treprostinil in PH Associated With Left Heart Disease or Chronic Lung Disease
  • Ferroportin Inhibition Attenuates Pulmonary Hypertension in Hypoxic Sickle Cell Disease Mice 
  • Artificial Intelligence-Based Echocardiography in Pulmonary Arterial Hypertension 
Community Calls
19 December 2025

In this PH Community Call, we discussed: 

  • Monocytes and interstitial macrophages contribute to hypoxic pulmonary hypertension 
  • Effects of kettlebell exercise training on functional capacity and metabolic costs of activities of daily living in patients with pulmonary arterial hypertension: A randomized controlled trial - ScienceDirect 
Community Calls
24 April 2025

In this Community Call, we discussed:

  • Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension
  • ZENITH trial & a long-term follow-up study of Sotatercept for treatment of Pulmonary Arterial Hypertension: Interim results of SOTERIA. Our Community Call host Katrina Barry, participant in the long-term follow-up study of SOTERIA, joined the discussion with Aaron Waxman to answer any patient-related audience questions
Community Calls